[1]
Chiu, H.-Y. et al. 2018. Safety Profile of Secukinumab in Treatment of Patients with Psoriasis and Concurrent Hepatitis B or C: A Multicentric Prospective Cohort Study. Acta Dermato-Venereologica. 98, 9 (Jun. 2018), 829–834. DOI:https://doi.org/10.2340/00015555-2989.